Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 27, 2022

SELL
$94.19 - $124.49 $707,366 - $934,919
-7,510 Closed
0 $0
Q4 2021

Jan 31, 2022

BUY
$119.57 - $139.07 $277,282 - $322,503
2,319 Added 44.67%
7,510 $962,000
Q3 2021

Nov 03, 2021

BUY
$109.17 - $142.35 $566,701 - $738,938
5,191 New
5,191 $691,000
Q2 2021

Jul 30, 2021

SELL
$100.34 - $115.69 $161,547 - $186,260
-1,610 Closed
0 $0
Q1 2021

Apr 29, 2021

SELL
$101.51 - $125.27 $803,959 - $992,138
-7,920 Reduced 83.11%
1,610 $170,000
Q4 2020

Jan 28, 2021

SELL
$85.88 - $105.36 $1.52 Million - $1.87 Million
-17,736 Reduced 65.05%
9,530 $992,000
Q3 2020

Oct 29, 2020

SELL
$72.74 - $92.5 $52,081 - $66,230
-716 Reduced 2.56%
27,266 $2.34 Million
Q2 2020

Jul 24, 2020

BUY
$48.02 - $79.04 $260,364 - $428,554
5,422 Added 24.03%
27,982 $2.05 Million
Q1 2020

Apr 29, 2020

BUY
$36.95 - $62.95 $229,311 - $390,667
6,206 Added 37.95%
22,560 $1.17 Million
Q4 2019

Jan 27, 2020

SELL
$47.06 - $56.64 $344,526 - $414,661
-7,321 Reduced 30.92%
16,354 $921,000
Q3 2019

Oct 28, 2019

BUY
$47.45 - $58.05 $148,044 - $181,116
3,120 Added 15.18%
23,675 $1.13 Million
Q2 2019

Jul 30, 2019

BUY
$39.26 - $54.21 $324,601 - $448,208
8,268 Added 67.29%
20,555 $1.11 Million
Q1 2019

Apr 30, 2019

SELL
$29.84 - $43.92 $99,904 - $147,044
-3,348 Reduced 21.41%
12,287 $499,000
Q4 2018

Feb 01, 2019

SELL
$29.95 - $46.34 $291,293 - $450,702
-9,726 Reduced 38.35%
15,635 $487,000
Q3 2018

Nov 05, 2018

SELL
$40.12 - $45.55 $620,576 - $704,567
-15,468 Reduced 37.88%
25,361 $1.16 Million
Q2 2018

Jul 30, 2018

BUY
$38.72 - $42.52 $981,977 - $1.08 Million
25,361 Added 163.96%
40,829 $1.71 Million
Q1 2018

May 02, 2018

BUY
$39.4 - $47.39 $609,439 - $733,028
15,468 New
15,468 $635,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.